Trials / Terminated
TerminatedNCT02335489
A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
14-SMI-2013 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of neuropathic pain of the foot and/or lower limb
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation with the commercially available Axium neurostimulator |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-01-09
- Last updated
- 2019-02-04
- Results posted
- 2017-08-02
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02335489. Inclusion in this directory is not an endorsement.